A recent study suggests that patients who discontinue new GLP-1 drugs like Wegovy and Mounjaro can put back on shed pounds much more quickly than those who halt conventional lifestyle regimens.
Published data in a major medical journal points out that while overweight people can lose substantial amounts of their total mass while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"People purchasing such drugs must be informed of the danger of rapid rebound weight gain when the medication is stopped," cautioned expert Dr. Susan Jebb.
Such speed of regain suggests a return to original mass in about 18 months.
Comparing Treatments
The research, which reviewed dozens of trials involving thousands of participants, contrasted the outcomes of the injectable medications with other pills.
The team emphasize that people who shed pounds through diet and exercise usually experience a slower creep back—perhaps 0.1 kg a month—after stopping.
Explaining the Fast Rebound
Doctors suggest the way of the drugs accounts for the accelerated weight return.
These medications copy a natural hormone called GLP-1, which controls hunger.
"Artificially providing the hormone concentrations far above than the body's typical production could lead to the system to produce less of its own natural hormone, and could reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics expert.
"Withdrawal of this hormone supplement results in appetite is unsuppressed, making overeating far more likely."
An Ongoing Condition?
Medical guidelines recommend the jabs for individuals with weight-linked medical conditions, alongside recommended lifestyle changes.
Many experts contend that, considering the significant potential of weight regain, the treatment might need to be ongoing.
This view is echoed by drug manufacturers, who note that the results "emphasize the long-term character of obesity," akin to managing conditions like diabetes.
User Testimonies
Individuals who have stopped the medication explain a sudden resurgence of appetite.
"I experienced a trigger flipping and you become extremely hungry," said a patient.
This difficulty is worsened if patients have not established lasting dietary or behavioural modifications during treatment.
Significant Adoption
Survey data indicate that millions of adults in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Use is more common among women than males.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
In conclusion, experts stress that while the jabs are potent tools for weight loss, they are not a magic fix and lasting health benefits likely depends on integrated lifestyle changes.
